The Overdose Response Strategy (ORS) is an unprecedented and unique public health-public safety partnership between the Office of National Drug Control Policy (ONDCP) and the U.S. Centers for Disease Control and Prevention (CDC) through their support of the High Intensity Drug Trafficking Areas (HIDTA) program and the CDC Foundation. At its core, the ORS is an example of a cross-agency, interdisciplinary collaboration with a single mission of reducing overdose deaths and saving lives across the United States.
WHO WE ARE
The ORS, a partnership between CDC and ONDCP, with support from HIDTA and the CDC Foundation, has grown significantly since its launch. The program began in 2015 with only five originating HIDTAs, covering 15 states. Today, the program includes all 33 HIDTAs, covering all 50 states, the District of Columbia (DC), Puerto Rico and the U.S. Virgin Islands.
When public health and public safety—each bringing distinct perspectives and expertise—work together toward a shared goal, the impact is profound.
WHAT WE DO
The construction industry faces significant overdose risks, as workers may experience job-related injuries and seek opioids to manage pain while continuing to work. Concerns about reporting workplace injuries, including
A gap in naloxone access can result in a missed opportunity to reduce the risk of a subsequent overdose. The Indiana Overdose Response Strategy (ORS) team identified that a
The 2026 FIFA World Cup brought international visitors to host cities and surrounding communities across the United States, creating opportunities to share information about overdose risks and response. The
In a joint statement released by the White House, the Centers for Disease Control and Prevention (CDC) and the Office of National Drug Control Policy (ONDCP) recognized the Overdose